Cargando…
Neonatal cytokines and chemokines and risk of Autism Spectrum Disorder: the Early Markers for Autism (EMA) study: a case-control study
BACKGROUND: Biologic markers of infection and inflammation have been associated with Autism Spectrum Disorders (ASD) but prior studies have largely relied on specimens taken after clinical diagnosis. Research on potential biologic markers early in neurodevelopment is required to evaluate possible ca...
Autores principales: | Zerbo, Ousseny, Yoshida, Cathleen, Grether, Judith K, Van de Water, Judy, Ashwood, Paul, Delorenze, Gerald N, Hansen, Robin L, Kharrazi, Marty, Croen, Lisa A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080514/ https://www.ncbi.nlm.nih.gov/pubmed/24951035 http://dx.doi.org/10.1186/1742-2094-11-113 |
Ejemplares similares
-
Autism with Intellectual Disability is Associated with Increased Levels of Maternal Cytokines and Chemokines During Gestation
por: Jones, Karen L., et al.
Publicado: (2016) -
Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study
por: Goines, Paula E, et al.
Publicado: (2011) -
A Genome-Wide Survey of Transgenerational Genetic Effects in Autism
por: Tsang, Kathryn M., et al.
Publicado: (2013) -
Maternal mid-pregnancy C-reactive protein and risk of autism spectrum disorders: the early markers for autism study
por: Zerbo, O, et al.
Publicado: (2016) -
Maternal immune response and air pollution exposure during pregnancy: insights from the Early Markers for Autism (EMA) study
por: Volk, Heather E., et al.
Publicado: (2020)